Agilon Health, Inc. (AGL)
$
1.25
+0.02 (1.60%)
Key metrics
Financial statements
Free cash flow per share
-0.1705
Market cap
518 Million
Price to sales ratio
0.0878
Debt to equity
0.1012
Current ratio
1.1630
Income quality
0.1796
Average inventory
0
ROE
-0.6459
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilon Health, Inc. specializes in providing healthcare services for seniors in communities across the United States through primary care physicians. As of December 31, 2021, the company served approximately 238,000 senior members, which included 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. The company recorded an operating income of -$292,130,000.00 reflecting its earnings from core operations. Additionally, the total costs and expenses for the company are $6,352,660,000.00 reflecting its overall spending. The net total of other income and expenses is $43,304,000.00 reflecting non-core financial activities. The EBITDA is -$218,186,000.00 a key indicator of the company's operational profitability. Furthermore, the weighted average number of diluted shares outstanding is $410,966,000.00 reflecting potential dilution effects. Agilon Health, Inc., which was formerly known as Agilon Health Topco, Inc. until March 2021, was founded in 2016 and is based in Austin, Texas. In the financial market, the stock is affordable at $2.25 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $9,458,606.00 indicating strong liquidity. With a market capitalization of $518,028,750.00 the company is classified as a small-cap player, which can provide unique opportunities for growth. It is a key player in the $Medical - Care Facilities industry, contributing significantly to the overall market landscape. Moreover, it belongs to the $Healthcare sector, driving innovation and growth within its market niche. Together, these attributes highlight the company's standing and potential for investors seeking involvement in the healthcare sector focused on senior care.
Is Agilon Health, Inc. (AGL) a good investment?
Investing in Agilon Health, Inc. (AGL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Agilon Health, Inc. (AGL)'s stock forecast?
Analysts predict Agilon Health, Inc. stock to fluctuate between $0.71 (low) and $6.08 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilon Health, Inc.'s market capitalization?
As of 2025-08-20, Agilon Health, Inc.'s market cap is $518,028,750, based on 414,423,000 outstanding shares.
How does Agilon Health, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Agilon Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Agilon Health, Inc. pay dividends?
Agilon Health, Inc. pays dividends. The current dividend yield is 5.81%, with a payout of $0.45 per share.
How can I buy Agilon Health, Inc. (AGL) stock?
To buy Agilon Health, Inc. (AGL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AGL. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilon Health, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Agilon Health, Inc. perform in the last earnings report?
Revenue: $6,060,530,000 | EPS: -$0.63 | Growth: -1.56%.
Where can I find Agilon Health, Inc.'s investor relations reports?
Visit https://agilonhealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilon Health, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilon Health, Inc. stock?
All-time high: $38.47 (2021-09-02) | All-time low: $0.71 (2025-08-05).
What are the key trends affecting Agilon Health, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
prnewswire.com
NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
seekingalpha.com
AGL Energy Limited (OTCPK:AGLNF) Q4 2025 Earnings Conference Call August 12, 2025 9:00 PM ET Company Participants Damien Nicks - MD, CEO & Director Gary Brown - Chief Financial Officer James Thompson - Head of Investor Relations Jo Egan - Chief Customer Officer Markus Brokhof - Chief Operating Officer Conference Call Participants Anthony Moulder - Jefferies LLC, Research Division Dale Johannes Koenders - Barrenjoey Markets Pty Limited, Research Division Gordon Alexander Ramsay - RBC Capital Markets, Research Division Henry Meyer - Goldman Sachs Group, Inc., Research Division Ian Myles - Macquarie Research Robert Koh - Morgan Stanley, Research Division Tom Allen - UBS Investment Bank, Research Division James Thompson Thank you for standing by, and welcome to the AGL Energy Full Year Results Briefing Conference Call. [Operator Instructions] I would now like to hand over the conference to Managing Director and Chief Executive Officer, Mr.
prnewswire.com
LOS ANGELES , Aug. 12, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of agilon health, inc. ("Agilon" or "the Company") (NYSE: AGL) for violations of the securities laws.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
globenewswire.com
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
prnewswire.com
NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
seekingalpha.com
agilon health, inc. (NYSE:AGL ) Q2 2025 Earnings Conference Call August 5, 2025 5:30 PM ET Company Participants Evan Smith - Corporate Participant Jeffrey Alan Schwaneke - Executive VP & CFO Ronald Allan Williams - Chairman of the Board Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Craig Jones - BofA Securities, Research Division Eduardo Enrique Ron - Truist Securities, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division George Robert Hill - Deutsche Bank AG, Research Division Jack Garner Slevin - Jefferies LLC, Research Division Jenny Shen - BTIG, LLC, Research Division Justin Lake - Wolfe Research, LLC Lance Arthur Wilkes - Sanford C.
globenewswire.com
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Agilon Health, Inc. (NYSE: AGL) regarding possible violations of federal securities laws.
globenewswire.com
ATLANTA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether agilon health, inc. (“agilon health” or the “Company”) (NYSE: AGL) complied with federal securities laws. On August 4, 2025, agilon health announced that its CEO and President had resigned and that it was “suspending its previously issued full-year 2025 financial guidance and related assumptions.” Following this news, the price of the Company's stock dropped.
See all news
